|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1994-4-22
|
|
pubmed:abstractText |
Endometrial carcinoma is generally diagnosed only after the onset of postmenopausal bleeding. Although most patients with Stage I disease can be cured, the prognosis worsens significantly when the tumor is no longer confined to the uterine corpus. Serum CA 125 is elevated in only 10-20% cases of Stage I and II endometrial carcinoma. A serum tumor marker that can detect early stage endometrial cancer might aid in management of the disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1855-8
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8137210-Antigens, Neoplasm,
pubmed-meshheading:8137210-Antigens, Tumor-Associated, Carbohydrate,
pubmed-meshheading:8137210-Carcinoma,
pubmed-meshheading:8137210-Endometrial Neoplasms,
pubmed-meshheading:8137210-Female,
pubmed-meshheading:8137210-Glycoproteins,
pubmed-meshheading:8137210-Humans,
pubmed-meshheading:8137210-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:8137210-Neoplasm Staging,
pubmed-meshheading:8137210-Prognosis,
pubmed-meshheading:8137210-Proteins,
pubmed-meshheading:8137210-Sensitivity and Specificity,
pubmed-meshheading:8137210-Tumor Markers, Biological
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
OVX1 as a marker for early stage endometrial carcinoma.
|
|
pubmed:affiliation |
Department of Medicine, Duke University Medical Center, Durham, NC 27710.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
